Stephens & Co. Maintains Overweight on Ardent Health, Raises Price Target to $21
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsPrice Target
Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and raises the price target from $13 to $21.
Stephens & Co. analyst Scott Fidel maintains Ardent Health (NYSE:ARDT) with a Overweight and raises the price target from $13 to $21.